Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intake.

Dhôte, R; Bergmann, J F; Leglise, P; Chassany, O; Elkharrat, D; Conort, O; Caulin, C

Dhôte, R; Bergmann, J F; Leglise, P; Chassany, O; Elkharrat, D; Conort, O; Caulin, C.

Affiliation

Dhôte R; Therapeutics Research Unit, Hôpital Lariboisière, France.

Clin Pharmacol Ther ; 57(4): 461-70, 1995 Apr.

Article in En | MEDLINE | ID: mdl-7712676

Subject(s)

Gastrointestinal Transit/physiology; Saliva/metabolism; Sulfapyridine/metabolism; Sulfasalazine/metabolism; Adult; Female; Humans; Linear Models; Male; Reference Values; Sulfapyridine/blood; Sulfasalazine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfasalazine / Saliva / Sulfapyridine / Gastrointestinal Transit Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 1995 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links